Although previous studies have focused on the anti‐inflammatory and neuroprotective roles of LXRβ agonists in neurodegenerative diseases, this study is the first to investigate their application in an FCD‐related animal model and their direct effects on glial migration and differentiation. This evidence concerns the gene NR1H2 and fleck corneal dystrophy.